22000

employees

140

countries in which
the Company’s medicines
are distributed

20%

Over 20% of revenue from
brand-name medicines invested
in R&D each year

€ 5.9 billion

in revenue in 2023/2024
including 4.5 billion for branded drugs and
1.4 billion for generic drugs

3 therapeutic areas

Oncology, cardiometabolism & venous diseases, neurology

Because passing on to future generations a world that can ensure access to quality healthcare for all is our vision for the future, at Servier, around the world, we are ready to meet the healthcare challenges of tomorrow, for and with patients.

Discover our corporate video